Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-25-001999

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 60.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.04M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$170.93K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$26.18K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$432.62K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$317.52K
Stockholders Equity Q3 2025 · Mar 31, 2025 −$303.91K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$294.97K
Stockholders Equity Q3 2025 · Sep 30, 2024 −$285.5K
Stockholders Equity Q3 2025 · Jun 30, 2024 −$276.4K
Stockholders Equity Q3 2025 · Mar 31, 2024 −$267.31K
Stockholders Equity Q3 2025 · Dec 31, 2023 −$257.01K
Current Liabilities Q3 2025 · Sep 30, 2025 $436.94K
Current Liabilities Q3 2025 · Dec 31, 2024 $326.95K
Current Assets Q3 2025 · Sep 30, 2025 $4.32K
Current Assets Q3 2025 · Dec 31, 2024 $5.08K
Total Assets Q3 2025 · Sep 30, 2025 $4.32K
Total Assets Q3 2025 · Dec 31, 2024 $31.97K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Sga Expense Q3 2025 · Sep 30, 2025 $115.1K
Sga Expense Q3 2025 · Sep 30, 2025 $137.65K
Sga Expense Q3 2025 · Sep 30, 2024 $9.11K
Sga Expense Q3 2025 · Sep 30, 2024 $28.49K
Net Income Q3 2025 · Sep 30, 2025 −$117.81K
Net Income Q3 2025 · Sep 30, 2025 −$143.67K
Net Income Q3 2025 · Jun 30, 2025 −$15.56K
Net Income Q3 2025 · Mar 31, 2025 −$10.3K
Net Income Q3 2025 · Sep 30, 2024 −$10.23K
Net Income Q3 2025 · Sep 30, 2024 −$31.62K
Net Income Q3 2025 · Jun 30, 2024 −$10.14K
Net Income Q3 2025 · Mar 31, 2024 −$11.25K
Operating Income Q3 2025 · Sep 30, 2025 −$115.1K
Operating Income Q3 2025 · Sep 30, 2025 −$137.65K
Operating Income Q3 2025 · Sep 30, 2024 −$9.11K
Operating Income Q3 2025 · Sep 30, 2024 −$28.49K
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0